Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Teva Pharma Industries Ltd ADR (TEVAy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Teva ADR historical data, for real-time data please try another search
7.70 0.00    0.00%
02/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US8816242098 
S/N:  883035
  • Volume: 0
  • Bid/Ask: 7.55 / 7.79
  • Day's Range: 7.56 - 7.70
Teva ADR 7.70 0.00 0.00%

TEVAy Recent Sentiments

 
This page contains information on users’ sentiments for the Teva Pharma Industries Ltd ADR stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 20, 2021 andy joy   7.70 Feb 12, 2021 @ 7.70 0.00%
Sep 30, 2020 רפי מנטין   7.74 Oct 23, 2020 @ 7.70 -0.52%
Sep 14, 2020 Максим Костинов   7.48 Oct 09, 2020 @ 7.70 +2.94%
Aug 17, 2020 רפי מנטין   9.71 Sep 11, 2020 @ 7.43 -23.48%
Jul 22, 2020 רפי מנטין   10.68 Aug 14, 2020 @ 9.68 -9.36%
Jul 01, 2020 isaac assor   10.86 Jul 24, 2020 @ 9.96 -8.29%
Jun 23, 2020 Patrick Molitor   11.48 Jul 17, 2020 @ 10.68 -6.97%
Jun 17, 2020 Mario Schmidt   10.66 Jul 10, 2020 @ 10.26 -3.75%
Jun 03, 2020 רפי מנטין   11.60 Jun 26, 2020 @ 11.08 -4.48%
May 28, 2020 Sergio González   11.80 Jun 19, 2020 @ 11.22 -4.92%
May 27, 2020 צורי שיר   11.32 Jun 01, 2020 @ 11.76 +3.89%
May 25, 2020 Gustaaf Verstraete   11.00 Jun 19, 2020 @ 11.22 +2.00%
May 19, 2020 Michael Bleiberg   10.68 Jun 12, 2020 @ 9.99 -6.46%
May 05, 2020 Shon Cash   9.08 May 29, 2020 @ 11.38 +25.33%
Apr 23, 2020 Thorsten Wentzel   9.16 May 15, 2020 @ 10.42 +13.76%
Apr 17, 2020 Michael Bleiberg   9.81 May 08, 2020 @ 10.58 +7.85%
Mar 23, 2020 Shimi Roham   6.78 Apr 17, 2020 @ 9.38 +38.35%
Jan 27, 2020 David Ronin   8.84 Feb 21, 2020 @ 12.14 +37.33%
Jan 21, 2020 JJ ZZ   9.20 Feb 14, 2020 @ 11.26 +22.39%
Jan 14, 2020 Gerhard Lukas   8.35 Feb 07, 2020 @ 11.06 +32.46%
Dec 30, 2019 Mac Mac   8.85 Jan 24, 2020 @ 9.17 +3.62%
Dec 27, 2019 Dominik Höbel   9.11 Jan 17, 2020 @ 9.32 +2.31%
Nov 26, 2019 Samuel Vanwaelfelghem   9.86 Dec 20, 2019 @ 9.01 -8.62%
Oct 28, 2019 Alessandro Pollio   7.26 Nov 14, 2019 @ 8.88 +22.31%
Sep 09, 2019 Cristina Dolcini   6.34 Oct 04, 2019 @ 6.31 -0.47%
Aug 09, 2019 Esben Falk   6.42 Aug 30, 2019 @ 6.24 +2.80%
Aug 07, 2019 eli shwartz   6.52 Aug 30, 2019 @ 6.24 -4.29%
Jul 29, 2019 Cihan Buffet   7.48 Aug 23, 2019 @ 6.44 -13.90%
Jul 29, 2019 Attila Nagy   7.26 Aug 23, 2019 @ 6.44 -11.29%
Jul 24, 2019 Mike Oslislok   7.08 Aug 16, 2019 @ 5.74 -18.93%
Jul 02, 2019 Cihan Buffet   8.34 Jul 26, 2019 @ 6.84 -17.99%
Jun 18, 2019 Gerhard Lukas   7.56 Jul 12, 2019 @ 8.18 +8.20%
Jun 05, 2019 Kyriakakis Michael   8.70 Jun 28, 2019 @ 8.14 -6.44%
May 29, 2019 Nicolai Freltoft   9.86 Jun 21, 2019 @ 7.36 -25.35%
May 23, 2019 Giulio Di Giulio   10.30 Jun 14, 2019 @ 7.66 -25.63%
May 15, 2019 Raimo Tikkanen   10.25 Jun 07, 2019 @ 8.20 +20.00%
Apr 23, 2019 Sandi Lončarič   13.20 May 17, 2019 @ 10.45 -20.83%
Feb 13, 2019 HongBae Park   17.35 Mar 15, 2019 @ 14.41 +16.95%
Feb 06, 2019 Samuel Vanwaelfelghem   17.50 Mar 08, 2019 @ 14.31 -18.23%
Jan 14, 2019 רפי מנטין   15.81 Feb 14, 2019 @ 17.27 +9.23%
Dec 10, 2018 Eyal Zangi   16.39 Jan 09, 2019 @ 17.27 +5.37%
Nov 09, 2018 Igor Bittner   20.69 Dec 09, 2018 @ 17.27 +16.53%
Oct 22, 2018 Dmitry Zadorozhny   18.75 Nov 21, 2018 @ 17.27 -7.89%
Sep 03, 2018 Dmitry Zadorozhny   19.81 Oct 03, 2018 @ 27.33 -37.99%
Aug 22, 2018 Benedikt Kap   21.05 Sep 21, 2018 @ 20.87 -0.86%
Aug 03, 2018 Marius Wolf   18.94 Sep 02, 2018 @ 19.76 +4.33%
Jul 26, 2018 popup test   19.97 Aug 25, 2018 @ 19.95 +0.10%
Jun 07, 2018 David Jakobson   18.34 Jul 07, 2018 @ 20.59 +12.27%
May 14, 2018 Fritto Misto   16.35 Jun 13, 2018 @ 20.72 +26.73%
Jan 17, 2018 gbr Kvcs   17.32 Feb 16, 2018 @ 16.80 +3.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Comments

Write your thoughts about Teva Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Mar 23, 2024 9:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1% on a Friday with 9.13M volume someone is buying.
TSahi Livnoni
TSahi Livnoni Mar 13, 2024 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
simple story of debt reduction and value going up. revenue growth will set the pace will move up in the next 2-3 years to about 30-40$
ritchie lee
ritchie lee Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long trend starting
Ramba Łej
Kubizm Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hopefully ! Ive been w8ing for it for 3 y xD
Ramba Łej
Kubizm Sep 14, 2023 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
11,40 will hold as celling or convert to floor :)?
Ramba Łej
Kubizm Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looking good on pre-market. Wonder how USA downgrade might spoil the fun here
BumHunters Archer
JohnJenga Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
25 next year seems quite doable
Michael Christensen
Michael Christensen Aug 02, 2023 6:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Somebody know the consensus for Q2 today ?
Harel Cohen
Harel Cohen Aug 01, 2023 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
first real report of new CEO... it will be interesting
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email